COORDINATION:
Aleix Prat, Hospital Clínic de Barcelona & SOLTI President
Patricia Villagrasa, SOLTI’s Scientific Director
PRELIMINARY PROGRAM:
Predicting phenotypes using DNA-based data
Charles Perou, UNC Lineberger (USA)
Present and future of single cell sequencing in cancer
Holger Heyn, Centro Nacional de Análisis Genómico (Spain)
Immuno-oncology
Antoni Ribas, University of California Los Angeles and President of AACR (USA)
SPECIAL LECTURE
The future of cancer treatment from a pan-cancer point of view
José Baselga, EVP & President, Oncology R&D, Astrazeneca